DocStoX is a free AI-powered research platform for Indian equity markets, covering 5,700+ NSE & BSE stocks with prices, fundamentals, 326 financial ratios, shareholding, FII/DII flows, F&O, IPOs, a visual screener and AI stock scoring.

Yes. DocStoX has a free tier covering stock research, the screener, FII/DII data and educational guides, plus a free MCP API tier (50 tool calls/day) for AI assistants. A Pro plan adds higher limits and advanced features.

What data does DocStoX cover?

Every NSE & BSE listed stock (5,700+ instruments): EOD and intraday prices, income statement / balance sheet / cash flow, 326 ratios, quarterly shareholding, promoter pledge, mutual-fund holdings, FII/DII flows, F&O and option-chain data, analyst forecasts, IPOs, corporate actions and news.

Can AI assistants like ChatGPT or Claude use DocStoX data?

Yes. DocStoX runs a public Model Context Protocol (MCP) server at https://mcp.docstox.com/mcp with 93 tools, so Claude, ChatGPT, Cursor and other MCP clients can pull Indian market data directly. Setup and a free key are at https://docstox.com/mcp.

Neutral impactCompany

Avience Biomedicals Limited — Analysts/Institutional Investor Meet/Con. Call Updates

NSE 2 hrs ago·1 Oct 2026, 2:31 pm

Avience Biomedicals

Avience Biomedicals Limited has announced the outcome of its recent investor conference call. The company provided an update on its business operations and future strategy during the meeting. This disclosure is a standard regulatory requirement for listed entities to keep the market informed about their key interactions with the investment community.

For investors, this update serves as a transparency measure. It offers a glimpse into the company's current standing and management's outlook, which can be useful for gauging the company's direction. However, specific financial details or quantitative targets were not the primary focus of this announcement.

Moving forward, market participants should look for any new information regarding the company's pipeline or operational progress. Investors will likely track the stock's reaction to the news to gauge the market's sentiment towards the company's current trajectory.